---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-008268"
form_type: "8-K"
ticker: "HROW"
cik: "0001360214"
company_name: "HARROW, INC."
filed_at: "2022-03-31T23:59:59+00:00"
generated_at: "2026-06-26T11:47:21.972497+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Harrow Health announces board resignation of Kammer and appointment of Sternberg and Makary

## Summary
- Dr. Robert J. Kammer resigned from the board effective March 31, 2022; no disagreements cited.
- Board retained Kammer as a special advisor through end of 2022.
- Board expanded to six members; appointed Perry J. Sternberg and Dr. Marty Makary as independent directors.
- Sternberg is CEO of Corium, Inc.; Makary is chief of islet transplant surgery at Johns Hopkins Hospital.
- Sternberg and Makary will receive the Company's standard director compensation package as described in prior proxy.

## SEC filing metadata
- accession: 0001493152-22-008268
- form_type: 8-K
- ticker: HROW
- cik: 0001360214
- company_name: HARROW, INC.
- filed_at: 2022-03-31T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1360214/000149315222008268/0001493152-22-008268-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1360214/000149315222008268/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-008268
- JSON: https://secwatch.observer/filing/0001493152-22-008268.json
- Plain text: https://secwatch.observer/filing/0001493152-22-008268.txt

## Key facts
- Executive change
  Perry J. Sternberg was appointed as Director at HARROW, INC..
  - Action: appointed
  - Role: Director
  source text: the Board appointed Mr. Perry J. Sternberg and Dr. Marty Makary to fill the vacancies created by Dr. Kammer’s resignation and the expansion of the size of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1360214/000149315222008268/0001493152-22-008268-index.htm
- Executive change
  Dr. Robert J. Kammer resigned as Director at HARROW, INC..
  - Action: resigned
  - Role: Director
  source text: On March 31, 2022, Dr. Robert J. Kammer informed the Board of Directors (the “Board”) of Harrow Health, Inc. (the “Company”) that he is resigning as a member of the Company’s Board, with such resignation to be effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1360214/000149315222008268/0001493152-22-008268-index.htm
- Executive change
  Dr. Marty Makary was appointed as Director at HARROW, INC..
  - Action: appointed
  - Role: Director
  source text: the Board appointed Mr. Perry J. Sternberg and Dr. Marty Makary to fill the vacancies created by Dr. Kammer’s resignation and the expansion of the size of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1360214/000149315222008268/0001493152-22-008268-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.